Role of Circulating Tumor DNA in Gastrointestinal Cancers: Current Knowledge and Perspectives
Gastrointestinal (GI) cancers are major health burdens worldwide and biomarkers are needed to improve the management of these diseases along their evolution. Circulating tumor DNA (ctDNA) is a promising non-invasive blood and other bodily-fluid-based biomarker in cancer management that can help clin...
Main Authors: | Emilie Moati, Valerie Taly, Simon Garinet, Audrey Didelot, Julien Taieb, Pierre Laurent-Puig, Aziz Zaanan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/19/4743 |
Similar Items
-
Characterization of Plasma Cell-Free DNA Integrity Using Droplet-Based Digital PCR: Toward the Development of Circulating Tumor DNA-Dedicated Assays
by: Geoffroy Poulet, et al.
Published: (2021-05-01) -
The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers
by: Hariti Saluja, et al.
Published: (2018-07-01) -
The Position of Circulating Tumor DNA in the Clinical Management of Colorectal Cancer
by: Ana Regina de Abreu, et al.
Published: (2023-02-01) -
The efficient circulating immunoscore predicts prognosis of patients with advanced gastrointestinal cancer
by: Yamei Zhao, et al.
Published: (2022-07-01) -
Circulating MicroRNAs in Gastrointestinal Cancer
by: Masahisa Ohtsuka, et al.
Published: (2021-07-01)